Tech Company Financing Transactions

Achaogen Funding Round

Achaogen closed a $26 million Series B funding round on 10/10/2006. Investors included 5AM Ventures, Arch Venture Partners and Venrock.

Transaction Overview

Company Name
Achaogen
Announced On
10/10/2006
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Series B
Investors

5AM Ventures (Scott Rocklage)

Arch Venture Partners (Scott Minick)

Venrock (Bryan Roberts)

Versant Ventures (Camille Samuels)

Proceeds Purpose
The company will use the money to advance its lead antibacterial program through clinical proof of concept, and to progress additional programs through preclinical development.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Tower Pl. 400
San Francisco, CA 94080
USA
Phone
(833) 252-6400
Website
www.achaogen.com
Email Address
[email protected]
Overview
Achaogen is dedicated to addressing serious medical needs caused by the development of bacterial resistance to antibiotics.
Profile
Achaogen LinkedIn Company Profile
Social Media
Achaogen Company Twitter Account
Company News
Achaogen News
Facebook
Achaogen on Facebook
YouTube
Achaogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Blake Wise
  Blake Wise LinkedIn Profile  Blake Wise Twitter Account  Blake Wise News  Blake Wise on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/10/2006: Intelliworks venture capital transaction
Next: 10/12/2006: Morphotek venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.